Global Kras Inhibitors Market is driven by targeted therapy demand

a adăugat un sunet Health

2025-05-09 10:15:45 -

Kras inhibitors are a class of targeted oncology therapies designed to selectively inhibit mutations in the KRAS gene, one of the most frequently mutated oncogenes in human cancers. By blocking aberrant KRAS signaling pathways, these small-molecule drugs offer improved specificity over conventional chemotherapies, reducing off-target toxicity and enhancing patient outcomes. The growing pipeline...

0 Commentarii 0 Distribuiri 695 Views 0 previzualizare